A Study of a Device Used to Take Pictures of Skin Blood Flow
NCT03912376 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8
Last updated 2025-12-15
Summary
The purpose of this study is see fi the hyperspectral camera system (HCS) can measure skin blood flow (perfusion and oxygenation) in healthy people.
Conditions
- Basal Blood Flow
Interventions
- DIAGNOSTIC_TEST
-
Quest Hyperspectral Imaging System
In this camera 3 sensors are combined for optimal spectral imaging. For 2D reference, and to facilitate annotating the data, a high resolution (full HD) color image, recorded with an RGB-sensor, is included with each hyperspectral dataset.
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Michelle Bradbury, MD, PhD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-04-05
- Primary Completion
- 2024-09-23
- Completion
- 2024-09-23
Countries
- United States
Study Locations
More Related Trials
-
Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma
NCT02316795 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Testing a New Imaging Agent to Identify Cancer
NCT04692831 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer
NCT00071357 ·Status: COMPLETED
-
ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue.
NCT01993576 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging
NCT02510456 ·Status: COMPLETED
-
Detection of Amplification of Her2 Fluorescent in Situ Hybridization (FISH) in Breast Tissue Sections
NCT01066507 ·Status: COMPLETED
-
Improved Breast MRI With SWIFT
NCT01156987 ·Status: COMPLETED ·Phase: NA
-
High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
NCT03954431 ·Status: RECRUITING ·Phase: NA
-
Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients
NCT00952679 ·Status: UNKNOWN ·Phase: PHASE3
-
Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device
NCT04239105 ·Status: UNKNOWN
-
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis
NCT05369546 ·Status: RECRUITING
-
QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser
NCT01803516 ·Status: COMPLETED
-
Breast MRI as a Preoperative Tool for DCIS
NCT00605982 ·Status: COMPLETED ·Phase: NA
-
Role of 3D Tomography in Breast Cancer
NCT01090687 ·Status: COMPLETED
-
Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer
NCT05615298 ·Status: COMPLETED
-
Studying Blood Samples in Women With Breast Cancer or a History of Breast Cancer
NCT00898703 ·Status: COMPLETED
-
Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening
NCT03861975 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment
NCT02891681 ·Status: COMPLETED ·Phase: NA
-
Breast Cancer Risk Assessment Using Optical Breast Spectroscopy (OBS)
NCT00500383 ·Status: COMPLETED
-
Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer
NCT03650803 ·Status: COMPLETED ·Phase: NA
-
Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
NCT00620373 ·Status: COMPLETED ·Phase: NA
-
Assessing the Utility of Tissue Dielectric Constant (TDC) Measurements to Differentiate Breast Cancer From Healthy Breasts
NCT04561297 ·Status: COMPLETED ·Phase: NA
-
A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins
NCT01372631 ·Status: COMPLETED ·Phase: NA
-
NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo
NCT01934114 ·Status: TERMINATED
-
99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization
NCT03546478 ·Status: COMPLETED ·Phase: EARLY_PHASE1